Suchergebnisse - "Haanen, J"

PubPharm (177)

91

1137 Can Memorial Sloan Kettering Cancer Center (MSKCC) and Database Consortium (DCM) prognostic risk assessment be used to decide about cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma?

enthalten in: European urology / Supplements | 2014

von Noe, A. | Blank, C. | Horenblas, S. | +2

92

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von McDermott, D. | Haanen, J. | Chen, T. | +3

93

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

enthalten in: Annals of oncology | 2013

von McDermott, D. | Haanen, J. | Chen, T. | +3

94

A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Powles, T. | Kayani, I. | Sharpe, K. | +13

95

A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer

enthalten in: Annals of oncology | 2013

von Powles, T. | Kayani, I. | Sharpe, K. | +13

96

Transposon leads to contamination of clinical pDNA vaccine

enthalten in: Vaccine | 2013

von van der Heijden, I. | Gomez-Eerland, R. | van den Berg, J. | +5

97

Transposon leads to contamination of clinical pDNA vaccine

enthalten in: Vaccine | 2013

von van der Heijden, I. | Gomez-Eerland, R. | van den Berg, J. | +5

98

Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?

enthalten in: Cancer treatment reviews | 2013

von Nijenhuis, C. | Haanen, J. | Schellens, J. | +1

99

Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?

enthalten in: Cancer treatment reviews | 2013

von Nijenhuis, C. | Haanen, J. | Schellens, J. | +1

100

24 Prognostische waarde van Memorial Sloan Kettering Cancer Center (MSKCC-) en Heng-classificatie bij synchroon gemetastaseerd niercelcarcinoom (NCC) en de primaire tumor in situ in het tijdperk van targeted therapy

enthalten in: Tijdschrift voor urologie | 2013

von Noë, A. | Blank, C. | Horenblas, S. | +2